Research Shows GPs are Switched on to EPS

New research from doctors.net.uk has revealed that GPs' use of electronic prescriptions is gaining momentum. An online survey of 834 GPs in England found that 15% of respondents had already switched to EPS R2, with 25% of those not currently using electronic prescriptions planning to upgrade in 2014.

The research, conducted on behalf of NHS-contracted mail order pharmacy Pharmacy2U, is the first to present a comprehensive view of the EPS landscape in England.

It showed that many GPs have faith in an electronic future. Forty-three per cent of respondents - including those who have not yet switched - were confident that EPS would enable them to provide a more efficient repeat prescription service.

Confusion over patient choice
But the research also revealed confusion among GPs around the introduction of greater patient choice of pharmacy - a key element of EPS R2, as digital scripts remove the need for patients to take a paper copy to the pharmacy.

Almost half of the GPs surveyed (48%) admitted they did not know enough about the nominations process to explain it to patients. And 46% did not know that under EPS, patients have the freedom to nominate any EPS-enabled pharmacy, anywhere in England.

Despite this confusion, 56% agreed that greater choice of pharmacy was valuable because it allowed patients to find the most convenient option for them.

Teething troubles
The research also explored the practical issues involved in switching to digital prescriptions; 58% of GPs using EPS had experienced teething troubles when switching. Issues included lack of preparation among local pharmacies (55%) lack of DM&D coding (29%) and lack of training for practice staff (37%).

Dr Julian Harrison, a director of Pharmacy2U said: "It's encouraging to see the increased uptake of electronic prescriptions but concerning that a key element of the service - greater patient choice of pharmacy - is not yet fully understood by the profession."

Dr Donya Young, an early adopter of electronic prescriptions, is confident about the efficiency benefits of EPS R2. She said: "It is hard to see any negatives with EPS R2 once you address the initial preparation and staff training. The patients love being able to choose their most convenient pharmacy - wherever and whoever that may be. It has really helped our staff to improve efficiency at the practice, and being able to communicate speedily and accurately with our pharmacy colleagues has to be better and safer for all concerned."

In November 2013, MedeConnect, the research division of doctors.net.uk, surveyed 834 UK-registered GPs working in England to test understanding of different elements of EPS R2

Established in 1999, Pharmacy2U is the UK#s largest dedicated internet and mail order pharmacy. The company provides a free NHS mail order repeat prescription service. The service is enabled for EPS R2, making it an option for any patient whose GP uses electronic prescriptions.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...